PCVX as of Nov 4 · 14:39 ET
PCVXNasdaqBiological Products, (No Diagnostic Substances)

Vaxcyte, Inc. · Brief

Next report

5 days

Nov 9 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±10.9%
avg realized
±5.3%
Nov 5 '24±5.1%▼−3.24%×0.64
Feb 25 '25±16.1%▼−0.88%×0.05
May 7 '25±11.9%▲+8.45%×0.71
Aug 6 '25±10.9%▼−9.06%×0.83
Nov 4 '25±16.7%▼−2.49%×0.15
Q1 FY26±10.5%▲+2.75%×0.26
May 6 '26±7.2%▼−9.84%×1.36
Q2 FY26±8.6%▲+5.31%×0.62
quarterimplied−20%0+20%realized×
Q2 FY26±8.6%▲+5.31%×0.62
May '26±7.2%▼−9.84%×1.36
Q1 FY26±10.5%▲+2.75%×0.26
Nov '25±16.7%▼−2.49%×0.15
Aug '25±10.9%▼−9.06%×0.83
May '25±11.9%▲+8.45%×0.71
2 older reports
Feb '25±16.1%▼−0.88%×0.05
Nov '24±5.1%▼−3.24%×0.64
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

4disclosed supplier and customer ties in sec filingsSEC filings
5tracked funds holding PCVXN-PORT · Aug 31 '26

Bear1

28managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

PCVX report session
× = co-movement · max 499dSource: SEC filings · market data

Latest changes

30 daysAll changes
Nov 3impliedImplied move: ±9.9% into Nov 9 earnings (Nov 3 close).Source
Oct 20impliedImplied move: ±10.9% into Nov 3 earnings (Oct 20 close).Source
Oct 98-KMaterial agreement: Indenture with U.S. Bank Trust Company, National Association, as trustee.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.